4//SEC Filing
MANNING JOSEPH J 4
Accession 0001415889-22-001740
CIK 0000001800other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:18 PM ET
Size
7.7 KB
Accession
0001415889-22-001740
Insider Transaction Report
Form 4
MANNING JOSEPH J
Senior Vice President
Transactions
- Award
Common shares without par value
2022-02-18+15,523→ 67,502 total - Award
Option (right to buy)
2022-02-18+72,342→ 72,342 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (72,342 underlying)
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Since the date of the reporting person's last ownership report, he transferred 3,754 shares to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,114 on February 18, 2023, 24,114 on February 18, 2024, and 24,114 on February 18, 2025.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001695686
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:18 PM ET
- Size
- 7.7 KB